CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 82.67% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money

Trade Talis Biomedical Corporation - TLIS CFD

4.36
5.57%
  • Summary
  • Historical Data
Trading сonditions
Spread 0.15
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.024262 %
Charges from full value of position ($-4.61)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.024262%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.00204 %
Charges from full value of position ($0.39)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.00204%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5.00%
Stock exchange United States of America
Commission on trade 0%

Key Stats
Prev. Close 4.13
Open 4.15
1-Year Change -33.28%
Day's Range 3.95 - 4.38
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Aug 30, 2024 4.36 0.21 5.06% 4.15 4.38 3.94
Aug 29, 2024 4.13 0.06 1.47% 4.07 4.38 4.06
Aug 28, 2024 3.98 0.20 5.29% 3.78 3.98 3.78
Aug 27, 2024 3.83 -0.09 -2.30% 3.92 3.92 3.72
Aug 26, 2024 3.98 0.30 8.15% 3.68 3.98 3.60
Aug 23, 2024 4.36 0.32 7.92% 4.04 4.38 4.04
Aug 22, 2024 4.15 -0.14 -3.26% 4.29 4.55 4.15
Aug 21, 2024 4.26 0.13 3.15% 4.13 4.33 4.13
Aug 20, 2024 4.07 0.01 0.25% 4.06 4.29 4.03
Aug 19, 2024 4.39 0.00 0.00% 4.39 4.43 4.28
Aug 16, 2024 4.33 0.44 11.31% 3.89 4.33 3.89
Aug 15, 2024 4.07 -0.01 -0.25% 4.08 4.13 3.99
Aug 14, 2024 3.99 0.02 0.50% 3.97 4.13 3.78
Aug 13, 2024 4.03 0.19 4.95% 3.84 4.03 3.84
Aug 12, 2024 3.89 0.14 3.73% 3.75 4.03 3.75
Aug 9, 2024 3.73 -0.22 -5.57% 3.95 4.25 3.70
Aug 8, 2024 4.18 -0.20 -4.57% 4.38 4.39 3.95
Aug 7, 2024 4.53 0.05 1.12% 4.48 4.94 4.10
Aug 6, 2024 8.97 0.17 1.93% 8.80 9.03 8.48
Aug 5, 2024 8.68 0.15 1.76% 8.53 8.97 8.38

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
  • 2:1
  • 3:1
  • 5:1
  • 10:1
  • 20:1
Leverage
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Talis Biomedical Corporation Company profile

About Talis Biomedical Corp

Talis Biomedical Corporation. (Talis) Is engaged in developing molecular diagnostic tests for infectious diseases at the point of care. The Company is focused on developing and commercializing products that are designed to enable molecular testing for infectious diseases and other conditions. Talis is developing the Talis One platform, a cloud-enabled molecular diagnostic platform. The Talis One platform comprises a compact instrument, single-use test cartridges and software, including a central cloud database, which work together and are designed to provide central laboratory levels of accuracy. The platform is designed for use in non-laboratory settings, such as physicians’ offices, hospital emergency departments, urgent care clinics, ambulatory surgery centers, assisted living facilities, and cancer treatment and dialysis centers. The Company is also developing Talis One tests for respiratory infections, infections related to women’s health and sexually transmitted infections.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Talis Biomedical Corp revenues decreased 25% to $8.2M. Net loss increased from $91.1M to $192M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Basic Earnings per Share excluding Extraordinary Items decreased from -$3.88 to -$7.30.

Industry: Biotechnology & Medical Research (NEC)

1100 Island Drive
Suite 101
REDWOOD CITY
CALIFORNIA 94065
US

People also watch

BTC/USD

99,716.65 Price
-1.850% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 50.00

XRP/USD

2.33 Price
-4.650% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 0.01161

Gold

2,690.99 Price
-0.970% 1D Chg, %
Long position overnight fee -0.0160%
Short position overnight fee 0.0078%
Overnight fee time 22:00 (UTC)
Spread 0.30

Oil - Crude

69.70 Price
-0.500% 1D Chg, %
Long position overnight fee 0.0085%
Short position overnight fee -0.0305%
Overnight fee time 22:00 (UTC)
Spread 0.030

Still looking for a broker you can trust?

Join the 660,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading